Detalles de la búsqueda
1.
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Clin Infect Dis
; 69(5): 777-785, 2019 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481272
2.
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
J Infect Dis
; 215(1): 95-104, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077588
3.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833336
4.
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants.
J Pediatric Infect Dis Soc
; 12(5): 298-305, 2023 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029694
5.
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.
J Infect Dis
; 201(5): 720-9, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20132004
6.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
J Infect Dis
; 201(4): 600-7, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20078213
7.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833946
8.
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 20(7): 851-863, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32251641
9.
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
PLoS One
; 15(5): e0233151, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469893
10.
Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
Vaccine
; 37(14): 1978-1986, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30797634
11.
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Lancet HIV
; 6(4): e230-e239, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885692
12.
Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.
PLoS Negl Trop Dis
; 12(4): e0006442, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29702652
13.
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.
Lancet Infect Dis
; 18(10): 1088-1096, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120069
14.
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 17(8): 843-853, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28483414
15.
Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.
Vaccine
; 35(15): 1898-1906, 2017 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28285985
16.
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.
Front Immunol
; 8: 149, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275375
17.
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.
Front Immunol
; 8: 595, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28596770
18.
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.
Clin Vaccine Immunol
; 23(4): 315-25, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26865592
19.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27617268
20.
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 16(1): 31-42, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26546548